| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:2967.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
From the Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Rostock, Germany.
Correspondence to Christoph A. Nienaber, MD, Division of Cardiology, University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Str 6, 18057 Rostock, Germany. E-mail christoph.nienaber{at}med.uni-rostock.de
Received May 13, 2003; de novo received July 18, 2003; revision received September 23, 2003; accepted October 21, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results The concept of postsurgical endovascular stent-graft placement was evaluated with respect to feasibility and safety in 6 consecutive patients with late aneurysm formation after coarctation repair. All patients had aneurysm formation late after patch aortoplasty; placement of an elephant trunk during surgical repair of secondary type I dissection preceded formation of a local aneurysm in 2 cases. Patient age was 49±12 years, ranging from 31 to 68 years. Transluminal placement of customized stent-grafts was successful, with no 30-day or 1-year intervention-related mortality or morbidity. Follow-up survey of 11 to 47 months revealed optimal reconstruction of the thoracic aorta; 1 patient died 11 months after endovascular repair from cancer.
Conclusions Nonsurgical aortic reconstruction of postsurgical thoracic aneurysms forming late after coarctation repair is safe and feasible; interventional stent-graft placement has the potential to avoid repeat surgery of postsurgical aortic aneurysm.
Key Words: coarctation aneurysm grafting stents aorta
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
|
When offered a second (patients 1 through 4) and third (patient 5 and 6) surgical repair or customized endovascular treatment with optional surgical conversion, all patients opted for an endovascular procedure as an alternative to repeat surgery and signed a written informed consent form approved by the institutional ethics committee.
Endovascular Stent-Graft
The stent-graft prosthesis (Talent, MedtronicAVE) is based on a self-expanding circumferential nitinol stent covered with a Dacron shell; each stent is customized with respect to width, length, and configuration of each end (bare stent segment or covered ends for optimal apposition) and delivered from a 22F to 24F polytetrafluoroethylene (Teflon) housing; the nitinol rings are interconnected by a longitudinal wire to ensure stability and prevent twisting. Morphometric measurements from 3-dimensional MR scans served as blueprint for each customized configuration (Figure 1A and Figure 2A).
|
|
Imaging Protocol
All patients underwent spinecho (anatomical) MRI and 3-dimensional magnetic resonance angiography (MRA) with individual bolus tracking of gadoliniumdiethylenetriamine pentaacetic acid (gadolinium-DTPA; Magnevist, Schering). Gadolinium-DTPA produces contrast-induced T1-shortening effects and eliminates saturation problems from slow flow or turbulence-induced signal voids. A body-array coil was used for signal transmission and reception. With the use of an ultrafast gradient on a 1.5-T magnet (Magnetom Vision, Siemens Medical Systems), acquisition was performed in breathhold technique. A FLASH (fast low-angle shot) 3-dimensional sequence was used to create maximal-intensity projections; echo and repetition times were as short as 1.9 and 4.0 ms, respectively. With a field of view of 390 to 450 mm, a 512x512 matrix provided an in-plane resolution of 1.1x1.6 mm6. Slice thickness varied from 2 to 4 mm; a flip angle of 30 degrees was selected. Imaging of 64 interpolated contiguous slices with half-k-space data acquisition in the phase-encoding direction took 20 to 28 seconds. With subvolume multiplanar reconstruction, MR scans and angiograms were evaluated for morphometric measurements for manufacturing the individualized endovascular prosthesis before stent implantation and for follow-up comparison.6
Implantation Technique
Stent-graft placement was performed in a cardiac catheterization laboratory rigged for surgical conversion with patients under general anesthesia and ventilation. The procedure was begun by injecting 5000 U of heparin and introducing a 6F pigtail catheter (Cordis) through the left brachial artery for landmarking the subclavian artery and intraprocedural aortography. The femoral or distal iliac artery was surgically exposed to accommodate a protected 0.035-inch guide wire. With wire position confirmed by fluoroscopy and transesophageal ultrasound, the stent-graft sheath was introduced at blood pressure titrated to 50 mm Hg by intravenous sodium nitroprusside before unloading the stent-graft; with correct positioning of the endoprothesis, cessation of flow and exclusion of the aneurysmal sac was documented by both color Doppler ultrasound and contrast aortography before removal of sheath and guide wire. The access site was closed by vascular microsurgery.
| Results |
|---|
|
|
|---|
Immediate and Long-Term Outcomes
Both intraprocedural and postprocedural outcomes were uneventful. Monitoring transesophageal ultrasound revealed intensifying echodensity (thrombosis) within minutes of aneurysm exclusion and no persisting endoleak. Transient postimplantation syndrome with mild leukocytosis, elevated levels of C-reactive protein, and moderately elevated body temperature occurred in all patients; maximal C-reactive protein level was 148 mg/L, and leukocyte count was 11±9x106/cm3 on day 3±2 but normalized thereafter.
Spin-echo MRI and MR angiography at discharge, 3-month, and 1-year follow-up documented normal patency of stent-grafts and complete fibrotic remodeling of the aorta with retraction of the aneurysm (shrinkage). Neither migration nor twisting of the stent-graft nor any leakage was noted. To ensure full exclusion of the postsurgical aneurysm, the grafted part of three endoprosthesis was placed over the origin of the left subclavian artery and led to a 55% reduction in distal arterial pressure; interestingly, no patient had pain or notable symptoms of dysfunction or fatigue (Figure 1, A and B). Distal left arm arterial pressure was unchanged in 3 patients. Individual follow-up is summarized in the Table; 1 patient died 11 months after stent-graft implantation from colorectal cancer, whereas all others enjoy an active, unrestricted life.
| Discussion |
|---|
|
|
|---|
Secondary surgical repair of postsurgical complications in complex forms of coarctation has been associated with high mortality and morbidity3; yet, optimal treatment is far from settled and in favor for palliative rather than corrective surgical repair because of considerable risk. Our encouraging results in 6 consecutive patients undergoing endovascular repair for postpatch-graft aortoplasty aneurysm suggest potential for a new nonsurgical option.3,11,16 The problem of postsurgical aneurysm formation has also been recognized after bypass grafting for long aortic coarctation and even after subclavian flap aortoplasty.12,16 Reoperation after previous patch-graft aortoplasty carries a 14% mortality rate and significant morbidity, including paralysis of the nervus recurrens and bleeding complications3,17; similarly, Kieffer et al18 found that open surgery for thoracic aneurysm in association with aberrant subclavian arteries is associated with a 23.5% mortality rate and a 13% paraplegia rate. Yet, conservative treatment of aneurysm after surgical coarctation repair remains unpredictable and is associated with a 100% rate of rupture within 15 years in the single-center experience of Knyshov et al.3
Our preliminary series demonstrates promising potential of endovascular stent-graft treatment in 6 patients with late aneurysm formation after complex surgical repair of coarctation (Figure 2, A and B). Transfemoral stent-graft deployment was safe and completed within 54±19 minutes in a multidisciplinary effort of an interventional cardiologist, a vascular surgeon for open femoral access, and anesthesiologist and led to favorable intrainterventional and postinterventional outcomes.6 Preservation of the integrity of the aorta by endovascular access rather than surgical resection has previously proven to protect spinal arteries and avoid neurological events.6,19
Considering the immediate vicinity of the aneurysm to the left subclavian artery, complete occlusion was necessary in 3 cases, followed by a postprocedural drop in ipsilateral systolic brachial pressure to 55 mm Hg, without any signs of malperfusion. Even at follow-up over 16 to 47 months, neither symptoms nor functional deficits nor differences in temperature were noted, lending credence to the notion that secondary transposition of the left subclavian artery is rarely necessary.20 Although conceptually promising, treatment by custom-made stent-grafts requires the support of long-term follow-up data. On the other hand, over several years of follow-up after stent-graft placement for the treatment of both thoracic and abdominal aneurysms, late adverse effects were infrequent, justifying the use of stent-grafts in younger patients after coarctation surgery.6,19,20
Finally, the custom design of each stent-graft currently limits the concept to patients undergoing elective procedures. In addition, sophisticated imaging techniques are required for planning and executing such delicate procedures. Given these prerequisites, placement of customized stent-grafts may be a promising nonsurgical strategy offered in specialized centers to avoid complicated secondary or tertiary aortic surgery.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Marcheix, Y. Lamarche, P. Perrault, R. Cartier, D. Bouchard, M. Carrier, L. P. Perrault, and P. Demers Endovascular management of pseudo-aneurysms after previous surgical repair of congenital aortic coarctation Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1004 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Inglessis and M. J. Landzberg Interventional Catheterization in Adult Congenital Heart Disease Circulation, March 27, 2007; 115(12): 1622 - 1633. [Full Text] [PDF] |
||||
![]() |
M. Gawenda, M. Aleksic, J. Heckenkamp, K. Kruger, and J. Brunkwall Endovascular repair of aneurysm after previous surgical coarctation repair J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1039 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Ramnarine Role of surgery in the management of the adult patient with coarctation of the aorta Postgrad. Med. J., April 1, 2005; 81(954): 243 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Kouchoukos, H. Ince, M. Petzsch, T. Rehders, S. Kische, T. Korber, F. Weber, and C. A. Nienaber Percutaneous Endovascular Repair of Aneurysm After Previous Coarctation Surgery * Response Circulation, June 8, 2004; 109(22): e317 - e317. [Full Text] [PDF] |
||||
![]() |
T. P. Graham Jr The year in congenital heart disease J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2132 - 2141. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |